•  
  •  
 

Abstract

CrossFit is a high-intensity sport that requires high cardiovascular fitness but aerobically-focused supplements are sparsely investigated within this demographic PURPOSE: to examine the efficacy of a novel ergogenic supplement blend on various cardiovascular metrics in CrossFit athletes. METHODS: 11 trained CrossFit athletes (30±6y; 3M/8F) were recruited for this acute, placebo-controlled study, whereby participants visited the laboratory on a single day to assess baseline resting heart rate (RHR), blood pressure (BP), and fingertip lactate (LAC) immediately prior to being randomly assigned to ingest either 4ml of a proprietary supplement blend (SUP; containing Beetroot, Ashwagandha, Arjuna, Rhodiola, and Cayenne) or an equivalent volume of placebo (PLA). Following a 2-hour period to facilitate peak supplement blood concentrations, resting assessments were repeated before performing a graded cycle ergometer test to measure maximal heart rate (MHR), peak oxygen consumption (VO2Peak), respiratory exchange ratio (RER), peak session LAC and ventilation, distance traveled, as well as post-exercise LAC (immediate [POST0M], 5-minutes [POST5M], and 30-minutes [POST30M] post-exercise) and heart rate recovery (HRR; 30-seconds [POST30S] and 2-minutes [POST2M]). All resting, as well as HRR and LAC values were assessed by separate (time x condition) two-way ANOVA with repeated measures. MHR, VO2PEAK, RER, ventilation, and cycle distance traveled were assessed using independent t-tests. All statistical tests were performed at a pRESULTS: Analyses revealed no significant acute supplement effects for resting BP or LAC, however, there was a main time effect, resulting in a significant decrease in RHR (73±12 vs 69±12 bpm; p=.015; ηp2=0.497) regardless of SUP or PLA condition. All other post-exercise variables were non-significant, notwithstanding a condition-collapsed drop in HR at POST2M versus POST30s (18±17 versus 55±20 Δbpm; p>.001; ηp2=0.881). CONCLUSION: Although ingestion of the experimental supplement failed to differentially impact any of the targeted cardiovascular metrics, these data should nevertheless be corroborated with a larger subject pool and a longitudinal design before conclusions can be inferred.

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.